Gf Fund Management Co. Ltd. Larimar Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $5.85 Trillion
- Q4 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,680 shares of LRMR stock, worth $5,678. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,680
Previous 1,841
8.75%
Holding current value
$5,678
Previous $5.95 Million
7.65%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LRMR
# of Institutions
157Shares Held
88.8MCall Options Held
6.44MPut Options Held
622K-
Deerfield Management Company, L.P. (Series C) New York, NY30.6MShares$103 Million1.84% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.05MShares$20.4 Million0.34% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.85MShares$19.8 Million8.2% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.9MShares$16.6 Million0.01% of portfolio
-
Opaleye Management Inc. Boston, MA3.72MShares$12.6 Million2.0% of portfolio
About Larimar Therapeutics, Inc.
- Ticker LRMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,269,200
- Market Cap $146M
- Description
- Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...